SARS-CoV-2 mutations contribute to increased viral transmissibility and immune escape,
compromising the effectiveness of existing vaccines and neutralizing antibodies. An in-depth …

Abstracts Recent evidence suggests that CD147 serves as a novel receptor for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti …

Currently, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has been widely spread around the world; nevertheless, so far there exist no specific …

In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no
specific and effective drugs for treating this disease have been reported until today …

Background SARS-CoV-2 is a novel human coronavirus, there is no specific antiviral drugs.
It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 …

In late 2019, the betacoronavirus SARS-CoV-2 was identified as the viral agent responsible
for the coronavirus disease 2019 (COVID-19) pandemic. Coronaviruses Spike proteins are …

The expressive number of deaths and confirmed cases of SARS-CoV-2 call for an urgent
demand of effective and available drugs for COVID-19 treatment. CD147, a receptor on host …

Abstract Effective treatments against Severe Acute Respiratory Syndrome coronavirus 2
(SARS-CoV-2) are urgently needed. Monoclonal antibodies have shown promising results …

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
variants is threatening public health around the world. Endocytosis functions as an important …

The combat against the Corona virus disease of 2019 (COVID-19), has created a chaos
among the healthcare institutions and researchers, in turn accelerating the dire need to …